Orchestra BioMed (OBIO) Institutional Ownership $2.58 -0.27 (-9.47%) Closing price 04/24/2025 04:00 PM EasternExtended Trading$2.61 +0.03 (+1.16%) As of 09:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Orchestra BioMed (NASDAQ:OBIO)CurrentInstitutional OwnershipPercentage53.55%Number ofInstitutional Buyers(last 12 months)19TotalInstitutional Inflows(last 12 months)$16.15MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$513.89K Get OBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OBIO Institutional Buying and Selling by Quarter Orchestra BioMed Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Millennium Management LLC21,513$86K0.0%N/A0.057% 2/17/2025Citadel Advisors LLC12,279$49K0.0%-39.0%0.032% 2/17/2025Bank of America Corp DE23,780$95K0.0%+42.0%0.063% 2/14/2025Boxer Capital Management LLC238,193$953K0.1%N/A0.627% 2/14/2025Northern Trust Corp236,761$947K0.0%+2.5%0.623% 2/14/2025The Manufacturers Life Insurance Company 37,009$148K0.0%+11.1%0.097% 2/14/2025Price T Rowe Associates Inc. MD487,170$1.95M0.0%-5.0%1.282% 2/13/2025Barclays PLC37,786$152K0.0%+18.9%0.099% 2/13/2025Wells Fargo & Company MN13,156$53K0.0%+43.6%0.035% 2/12/2025Geode Capital Management LLC572,441$2.29M0.0%+0.9%1.506% Get the Latest News and Ratings for OBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Orchestra BioMed and its competitors with MarketBeat's FREE daily newsletter. 2/12/2025JPMorgan Chase & Co.49,405$198K0.0%+354.5%0.130% 2/7/2025HighTower Advisors LLC68,500$274K0.0%+34.3%0.180% 1/17/2025 SG Americas Securities LLC12,785$51K0.0%+26.0%0.034% 11/21/2024SkyView Investment Advisors LLC12,284$63K0.0%-38.6%0.032% 11/19/2024Barclays PLC31,785$163K0.0%+281.3%0.084% 11/16/2024Geode Capital Management LLC567,219$2.92M0.0%+2.0%1.492% 11/15/2024Barclays PLC31,785$163K0.0%+281.3%0.084% 11/15/2024Jane Street Group LLC19,070$98K0.0%-19.8%0.050% 11/15/2024State Street Corp429,613$2.21M0.0%+12.4%1.130% 11/15/2024RTW Investments LP8,206,159$42.18M0.6%+46.0%21.587% 11/13/2024The Manufacturers Life Insurance Company33,305$171K0.0%-20.9%0.088% 11/12/2024Charles Schwab Investment Management Inc.217,008$1.12M0.0%+3.9%0.574% 11/1/2024ABLE Financial Group LLC13,402$69K0.0%N/A0.035% 10/3/2024 SG Americas Securities LLC10,143$52K0.0%N/A0.028% 8/16/2024SkyView Investment Advisors LLC20,000$163K0.0%N/A0.056% 8/15/2024The Manufacturers Life Insurance Company42,082$343K0.0%+8.4%0.118% 8/1/2024 Rhumbline Advisers26,439$215K0.0%+192.7%0.074% 7/26/2024Bank of New York Mellon Corp70,682$576K0.0%+115.7%0.197% 5/15/2024Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596% 5/11/2024Catalytic Wealth RIA LLC22,261$117K0.0%N/A0.062% 2/1/2024New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010% 10/27/2023Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014% 10/27/2023TD Asset Management Inc92,678$808K0.0%+100.0%0.259% 10/24/2023Bank of New York Mellon Corp40,290$351K0.0%+211.2%0.113% 10/18/2023 UMB Bank n.a.3,160$28K0.0%N/A0.009% 10/13/2023Arkadios Wealth Advisors51,595$450K0.0%N/A0.144% 8/24/2023Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744% 8/11/2023Atika Capital Management LLC64,651$453K0.0%N/A0.181% 5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230% 5/15/2023RTW Investments LP5,118,507$100.17M2.1%N/A45.652% Feds Just Admitted It—They Can Take Your Cash (Ad)Here’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousands of smart, forward-thinking individuals are making the move—out of the system and into real, untouchable assets. Because once your funds are frozen, it’s too late.👉 Click here to find out how to protect every dollar you’ve earned—before it disappears behind red 4/18/2023IFP Advisors Inc2,980$34K0.0%N/A0.027% (Data available from 1/1/2016 forward) OBIO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OBIO shares? During the previous two years, 30 institutional investors and hedge funds held shares of Orchestra BioMed. The most heavily invested institutionals were RTW Investments LP ($42.18M), Perceptive Advisors LLC ($14.37M), Boxer Capital LLC ($4.89M), Geode Capital Management LLC ($2.29M), State Street Corp ($2.21M), Price T Rowe Associates Inc. MD ($1.95M), and Charles Schwab Investment Management Inc. ($1.12M).Learn more on OBIO's institutional investors. What percentage of Orchestra BioMed stock is owned by institutional investors? 53.55% of Orchestra BioMed stock is owned by institutional investors. Learn more on OBIO's institutional investor holdings. Which institutional investors have been buying Orchestra BioMed stock? Of the 25 institutional investors that purchased Orchestra BioMed stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RTW Investments LP ($7.70M), Boxer Capital LLC ($250K), Boxer Capital Management LLC ($238.19K), Bank of New York Mellon Corp ($65.25K), Atika Capital Management LLC ($64.65K), Barclays PLC ($52.90K), and Arkadios Wealth Advisors ($51.60K). How much institutional buying is happening at Orchestra BioMed? Institutional investors have bought a total of 8,739,757 shares in the last 24 months. This purchase volume represents approximately $122.83M in transactions. Which Orchestra BioMed major shareholders have been selling company stock? The following institutional investors have sold Orchestra BioMed stock in the last 24 months: Perceptive Advisors LLC ($225.36K), Price T Rowe Associates Inc. MD ($77.03K), The Manufacturers Life Insurance Company ($8.78K), New York State Common Retirement Fund ($7.93K), Citadel Advisors LLC ($7.84K), SkyView Investment Advisors LLC ($7.72K), and Jane Street Group LLC ($4.71K). How much institutional selling is happening at Orchestra BioMed? Institutional investors have sold a total of 339,356 shares in the last 24 months. This volume of shares sold represents approximately $2.16M in transactions. Related Companies TMCI Institutional Ownership DCTH Institutional Ownership NPCE Institutional Ownership SMLR Institutional Ownership CLPT Institutional Ownership TCMD Institutional Ownership NNOX Institutional Ownership SMTI Institutional Ownership ZIMV Institutional Ownership STIM Institutional Ownership This page (NASDAQ:OBIO) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.